A, 4´-phosphopantetheine is covalently linked to an adenylyl group, whereas it is covalently linked to a serine hydroxyl group in acyl carrier proteins. 4´-phosphopantetheine is cofactor of enzymes that play a role in the biosynthesis of fatty acids, polypeptide antibiotics and polyketides (2). It was
(INTRODUCTION)
Coenzyme A (CoA) 1 and 4´-phosphopantetheine (PP) are essential cofactors for many enzymatic reactions and acyl-CoA derivatives are key intermediates in energy metabolism (1) . In coenzyme A, 4´-phosphopantetheine is covalently linked to an adenylyl group, whereas it is covalently linked to a serine hydroxyl group in acyl carrier proteins. 4´-phosphopantetheine is cofactor of enzymes that play a role in the biosynthesis of fatty acids, polypeptide antibiotics and polyketides (2). It was
Feodor Lynen who elucidated that the thiol group of the cysteamine moiety of coenzyme A is the functional group by activating substrates as thioesters (3) .
Coenzyme A is synthesized in five steps from pantothenate (vitamin B5) (4-6) and despite its biological significance only recently all the biosynthetic enzymes have been cloned and characterized in prokaryotes (7) (8) (9) (10) (11) and the human genes encoding the last four enzymatic steps in coenzyme A biosynthesis were identified last year (12) . In the first step, pantothenate is phosphorylated to 4´-phosphopantothenate by pantothenate kinase, which is encoded by the coaA gene. Then, (R)-4´-phospho-N-pantothenoylcysteine (PPC) is synthesized by the addition of cysteine to 4´-phosphopantothenate and in the next step, PPC is decarboxylated to 4´-phosphopantetheine. 4´-phosphopantetheine is converted to coenzyme A by the enzymes 4´-phosphopantetheine adenylyltransferase and dephospho-CoA kinase ( Fig. 1 ).
In plants, where coenzyme A metabolism is well-understood (13), little is known about its biosynthesis (14) . Recently, the Arabidopsis thaliana flavoprotein AtHAL3a that shows sequence homology to the bacterial flavoprotein Dfp (8, 15) , has been identified as the enzyme that catalyzes the decarboxylation of 4'-phosphopantothenoylcysteine to 4'-phosphopantetheine, the third step in coenzyme A biosynthesis (16) (17) (18) .
Bacterial and human sequences of coenzyme A biosynthetic genes are very different in some cases and therefore are interesting novel drug targets (12, 19) . Recently, N-substituted pantothenamides have been identified as inhibitors of the staphylococcal pantothenate kinase (20) and dipeptides were used as inhibitors of the bacterial phosphopantetheine adenylyltransferase activity (21). tions within the AtCoaD protein (A37V, I68V and V87I) and two within the AtCoaE protein (Q186R and F204I) compared with the GenBank entries. The PPC synthetase activity of AtCoaB was investigated using two different malE-AtCoaB clones; in one case, the AtCoaB sequence was the same as published in the GenBank, in the other case there were five mutations (deletion of G45M46 and the point mutations D10A, M137T, R150H and L268S). In this paper we do not differentiate between both variants and the term MBP-AtCoaB is used for both fusion proteins, because both were active in synthesizing 4´-phosphopantothenoylcysteine. fore the most serious candidate for the ascription of a PPC decarboxylase activity in yeast CoA biosynthesis (Fig. 3B ). (8, 16, 39) . In order to identify the PPC synthetase activity of A. thaliana, the fusion protein MBP-AtCoaB was incubated with 4´-phosphopantothenate and cysteine in presence of the coenzymes ATP and CTP; the enzymatic activity was analyzed using the described HPLC based assay (Fig. 6 ). It turned out that MBP-AtCoaB is active in synthesizing PPC using ATP as cofactor. We propose that in A. thaliana synthesis of PPC occurs via 4´-phosphopantothenoyl-AMP, because careful analysis of the HPLC data of the assays containing no cysteine reveals a compound that has a higher absorbance at 260 nm than at 280 nm. This compound is not present when the E. coli enzyme His-CoaB is used (data not shown; the intermediate of the E. coli enzyme, 4´-phosphopantothenoyl-CMP, has a higher absorbance at 280 nm than at 260 nm). Recently, it was shown that also the cloned human PPC synthetase uses ATP as cofactor and the activity of this enzyme was determined by measuring the release of pyrophosphate (12) . This supports our view that 4´-phosphopantothenoyl-AMP is the intermediate in synthesis of PPC in eukaryotes, whereas 4´-phosphopantothenoyl-CMP is the intermediate in prokaryotes (5, 11, 29 , cysteine, DTT and E. coli His-CoaA, the compounds PPC, 4´-phosphopantetheine, dephospho-CoA and coenzyme A were synthesized in vitro (Fig. 7 ).
AtCoaD-The
This clearly demonstrates that MBP-AtCoaD has 4´-phosphopantetheine adenylyltransferase and MBP-AtCoaE has dephospho-CoA kinase activity. Dephospho-CoA cannot be completely converted to CoA, since the used molar ration of ATP to pantothenate was only 3:1. AtCoaD is specific for 4´-phosphopantetheine and does not accept 4´-phosphopantothenoylcysteine (PPC) as a substrate (Fig. 8 B) as also has been shown for the 4´-phosphopantetheine adenylyltransferase activity from rat liver (41).
In vitro reconstitution of plant coenzyme A biosynthesis -After we have verified, that 4´-phosphopantothenate can be converted to coenzyme A using the enzymes MBP-AtCoaB, HisAtHAL3a (His-AtCoaC), MBP-AtCoaD and MBP-AtCoaE, the activity of the putative pantothenate kinase MBP-AtCoaA was analyzed (Fig. 8) . 
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